50 participants
Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-02
- Start Date:
- 2026-12-31
- Completion:
- 2029-08-31
Conditions
- Central Serous Chorioretinopathy (CSC)
Interventions
- DRUG
No Results Yet